| Feb 1, 2024 |
Feb 6, 2024 |
CNS Pharmaceuticals, Inc.
|
CFO |
Buy |
91.3
|
+66,666
|
181.30%
|
✗
|
$20K |
| Aug 22, 2023 |
Aug 23, 2023 |
CNS Pharmaceuticals, Inc.
|
CFO |
Buy |
91.3
|
+27,000
|
276.30%
|
✗
|
$34.2K |
| Apr 17, 2023 |
Apr 18, 2023 |
CNS Pharmaceuticals, Inc.
|
CFO |
Buy |
90.0
|
+3,100
|
50.40%
|
✗
|
$9.9K |
| Dec 6, 2021 |
Dec 7, 2021 |
CNS Pharmaceuticals, Inc.
|
CFO |
Buy |
82.5
|
+5,000
|
3.41%
|
✗
|
$4.7K |
| Nov 19, 2021 |
Nov 22, 2021 |
CNS Pharmaceuticals, Inc.
|
CFO |
Buy |
82.5
|
+4,500
|
3.17%
|
✗
|
$5.2K |
| Aug 24, 2020 |
Aug 25, 2020 |
CNS Pharmaceuticals, Inc.
|
CFO |
Buy |
97.5
|
+142,000
|
100.00%
|
✗
|
$289.7K |
| Aug 14, 2017 |
Aug 16, 2017 |
InfuSystem Holdings, Inc
|
CFO |
Buy |
91.3
|
+7,900
|
37.73%
|
✗
|
$15K |